Filing Details
- Accession Number:
- 0001437749-19-018657
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-09-18 20:01:33
- Reporting Period:
- 2019-09-17
- Accepted Time:
- 2019-09-18 20:01:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
834365 | Biolife Solutions Inc | BLFS | Electromedical & Electrotherapeutic Apparatus (3845) | 943076866 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1592238 | C Joseph Schick | C/O Biolife Solutions, Inc. 3303 Monte Villa Parkway, Suite 310 Bothell WA 98021 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-09-17 | 1,713 | $1.90 | 8,588 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-09-17 | 1,713 | $21.00 | 6,875 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2019-09-18 | 3,287 | $1.90 | 10,162 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-09-18 | 3,287 | $21.00 | 6,875 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option | Disposition | 2019-09-17 | 1,713 | $0.00 | 1,713 | $1.90 |
Common Stock | Employee Stock Option | Disposition | 2019-09-18 | 3,287 | $0.00 | 3,287 | $1.90 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
8,287 | 2016-03-15 | 2025-03-15 | No | 4 | M | Direct |
5,000 | 2016-03-15 | 2025-03-15 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019.